Greenwich LifeSciences (GLSI) News Today → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free GLSI Stock Alerts $14.87 +0.49 (+3.41%) (As of 02:45 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 4, 2024 | americanbankingnews.comShort Interest in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Drops By 6.3%June 3, 2024 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest UpdateGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) was the recipient of a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 177,100 shares, a drop of 6.3% from the April 30th total of 189,100 shares. Approximately 3.0% of the company's stock are short sold. Based on an average daily volume of 43,100 shares, the days-to-cover ratio is currently 4.1 days.May 26, 2024 | finance.yahoo.comGreenwich LifeSciences, Inc. (GLSI)May 24, 2024 | marketbeat.comHC Wainwright Brokers Lift Earnings Estimates for Greenwich LifeSciences, Inc. (NASDAQ:GLSI)Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Research analysts at HC Wainwright boosted their FY2024 earnings per share (EPS) estimates for Greenwich LifeSciences in a report issued on Wednesday, May 22nd. HC Wainwright analyst Y. Chen now anticipates that the company will post earnMay 23, 2024 | marketbeat.comGreenwich LifeSciences, Inc. Expected to Earn Q1 2025 Earnings of ($0.17) Per Share (NASDAQ:GLSI)Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Equities researchers at HC Wainwright issued their Q1 2025 earnings per share (EPS) estimates for shares of Greenwich LifeSciences in a research note issued to investors on Wednesday, May 22nd. HC Wainwright analyst Y. Chen forecasts thatMay 22, 2024 | marketbeat.comGreenwich LifeSciences (NASDAQ:GLSI) Receives Buy Rating from HC WainwrightHC Wainwright reiterated a "buy" rating and issued a $36.00 target price on shares of Greenwich LifeSciences in a research report on Wednesday.May 20, 2024 | investorplace.comGLSI Stock Earnings: Greenwich LifeSciences Beats EPS for Q1 2024April 15, 2024 | markets.businessinsider.comGLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023April 4, 2024 | insidertrades.comSnehal Patel Buys 3,000 Shares of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) StockApril 3, 2024 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Purchases $57,240.00 in StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 3,000 shares of the business's stock in a transaction that occurred on Monday, April 1st. The shares were acquired at an average cost of $19.08 per share, with a total value of $57,240.00. Following the completion of the transaction, the chief executive officer now directly owns 5,350,777 shares in the company, valued at approximately $102,092,825.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.March 27, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Acquires 2,500 SharesMarch 26, 2024 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires $49,950.00 in StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel bought 2,500 shares of the stock in a transaction on Friday, March 22nd. The stock was acquired at an average price of $19.98 per share, with a total value of $49,950.00. Following the completion of the acquisition, the chief executive officer now owns 5,347,777 shares of the company's stock, valued at approximately $106,848,584.46. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink.March 23, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Purchases 1,500 SharesMarch 16, 2024 | insidertrades.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Snehal Patel Acquires 4,100 SharesMarch 13, 2024 | globenewswire.comGreenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025March 12, 2024 | globenewswire.comGreenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in EuropeMarch 7, 2024 | finance.yahoo.comGreenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional SharesMarch 6, 2024 | marketbeat.comInsider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires 4,100 Shares of StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel acquired 4,100 shares of the business's stock in a transaction that occurred on Monday, March 4th. The shares were purchased at an average price of $13.03 per share, with a total value of $53,423.00. Following the completion of the acquisition, the chief executive officer now owns 5,340,277 shares of the company's stock, valued at approximately $69,583,809.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.March 2, 2024 | marketbeat.comGreenwich LifeSciences, Inc. (NASDAQ:GLSI) Forecasted to Post Q1 2024 Earnings of ($0.20) Per ShareGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - HC Wainwright issued their Q1 2024 earnings per share (EPS) estimates for Greenwich LifeSciences in a note issued to investors on Wednesday, February 28th. HC Wainwright analyst Y. Chen expects that the company will post earnings of ($0.2February 28, 2024 | markets.businessinsider.comExpanding Horizons: Bullish Buy Rating as Greenwich LifeSciences’s Breast Cancer Trial Goes Pan-EuropeanFebruary 27, 2024 | msn.comGreenwich LifeSciences stock jumps 8% on Phase 3 study expansionFebruary 27, 2024 | finanznachrichten.deGreenwich LifeSciences, Inc.: Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European CountriesFebruary 27, 2024 | globenewswire.comGreenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European CountriesFebruary 23, 2024 | benzinga.comGreenwich LifeSciences Stock (NASDAQ:GLSI) Dividends: History, Yield and DatesFebruary 22, 2024 | finanznachrichten.deGreenwich LifeSciences, Inc.: Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European RegulatorsFebruary 22, 2024 | msn.comGreenwich Lifesciences announces acceptance for Flamingo-01 trial by EMAFebruary 22, 2024 | finance.yahoo.comGreenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European RegulatorsFebruary 22, 2024 | marketbeat.comHC Wainwright Weighs in on Greenwich LifeSciences, Inc.'s FY2023 Earnings (NASDAQ:GLSI)Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Investment analysts at HC Wainwright boosted their FY2023 EPS estimates for shares of Greenwich LifeSciences in a research note issued on Tuesday, February 20th. HC Wainwright analyst Y. Chen now forecasts that the company will earn ($0.6February 22, 2024 | globenewswire.comGreenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European RegulatorsFebruary 21, 2024 | realmoney.thestreet.com2 Rare Insider Buys in a Frothy MarketFebruary 21, 2024 | marketbeat.comBrokers Offer Predictions for Greenwich LifeSciences, Inc.'s FY2024 Earnings (NASDAQ:GLSI)Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Analysts at HC Wainwright issued their FY2024 earnings estimates for shares of Greenwich LifeSciences in a research note issued to investors on Tuesday, February 20th. HC Wainwright analyst Y. Chen forecasts that the company will post earFebruary 20, 2024 | markets.businessinsider.comHC Wainwright & Co. Maintains Buy Rating for Greenwich LifeSciences: Here's What You Need To KnowFebruary 20, 2024 | marketbeat.comInsider Buying: Greenwich LifeSciences, Inc. (NASDAQ:GLSI) CEO Acquires 12,700 Shares of StockGreenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) CEO Snehal Patel purchased 12,700 shares of the business's stock in a transaction on Thursday, February 15th. The shares were bought at an average price of $11.07 per share, for a total transaction of $140,589.00. Following the purchase, the chief executive officer now directly owns 5,325,377 shares in the company, valued at approximately $58,951,923.39. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.February 20, 2024 | marketbeat.comGreenwich LifeSciences (NASDAQ:GLSI) PT Lowered to $36.00 at HC WainwrightHC Wainwright cut their target price on shares of Greenwich LifeSciences from $38.00 to $36.00 and set a "buy" rating for the company in a report on Tuesday.February 14, 2024 | msn.comWhy Greenwich Lifesciences (GLSI) Stock Is SkyrocketingFebruary 14, 2024 | morningstar.comGreenwich LifeSciences Shares Rise as Company Prepares FDA Filing for Breast Cancer ImmunotherapyFebruary 14, 2024 | globenewswire.comGreenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01December 21, 2023 | bbc.co.ukGreenwich: Closed pub reopens as community hubDecember 11, 2023 | finance.yahoo.comInsiders hold 54% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI), and they've been buying recentlyDecember 2, 2023 | yahoo.comGreenwich, United States - Weather Forecasts | Maps | News - Yahoo WeatherNovember 21, 2023 | finanznachrichten.deGreenwich LifeSciences, Inc.: Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024November 21, 2023 | finance.yahoo.comGreenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024November 14, 2023 | finance.yahoo.comGreenwich LifeSciences Insiders Added US$653.7k Of Stock To Their HoldingsNovember 1, 2023 | chron.comGreenwich election guide 2023: Meet the candidates running for officeSeptember 20, 2023 | theguardian.comUniversity of GreenwichSeptember 13, 2023 | finance.yahoo.comInsider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences IncJuly 1, 2023 | greenwichtime.comGreenwich's dual July 4th fireworks displays: Where, when and everything else you need to knowJune 27, 2023 | finance.yahoo.comGLSI - Greenwich LifeSciences, Inc.June 24, 2023 | greenwichtime.comCos Cob Democrat Jim Finn enters Greenwich first selectman raceJune 19, 2023 | marketbeat.comShort Interest in Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Decreases By 6.5%Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Rating) was the target of a significant drop in short interest during the month of May. As of May 31st, there was short interest totalling 226,200 shares, a drop of 6.5% from the May 15th total of 242,000 shares. Approximately 6.3% of the company's shares are short sold. Based on an average daily volume of 41,400 shares, the days-to-cover ratio is presently 5.5 days. Get Greenwich LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address 3 Dirt-Cheap Stocks You Can’t Afford to Ignore (Ad)Often, investors will overlook stocks just because they're cheap. It's a common thought that a cheap price tag means that something must be wrong with the company. But this couldn't be further from the case in many instances. Get your FREE look at these THREE companies right here. GLSI Media Mentions By Week GLSI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GLSI News Sentiment▼1.460.76▲Average Medical News Sentiment GLSI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GLSI Articles This Week▼21▲GLSI Articles Average Week Get Greenwich LifeSciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GLSI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: PBYI News Today TNGX News Today OLMA News Today EOLS News Today WVE News Today PAHC News Today PRAX News Today NUVB News Today LBPH News Today PLRX News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GLSI) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored